Hyperplasia of Mammary Glands is a complex disease, and there is no consensus or guideline for the treatment of this disease. This study was launched to investigate into the problem that which patients should be diagnosed as hyperplasia of mammary glands and which patients should be treated.
Females who meet the inclusion criteria will receive breast ultrasonography, mammography and pathological examinations by core needle biopsy. All participants will receive a follow-up at an 6-month interval for 2 years. During the follow-up period, whether the symptoms relieve will be evaluated.
Study Type
OBSERVATIONAL
Enrollment
5,000
the Second Hospital of Shandong Universtity
Jinan, Shandong, China
RECRUITINGClinical manifestations as an substitutive indicator for pathological diagnosis of hyperplasia of mammary glands
Time frame: 8 months
Clinical manifestations as an surgical indications for hyperplasia of mammary glands
Time frame: 8 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.